Navigation Links
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Date:12/16/2013

) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.

This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 - 2018 in terms of value in USD million.

Key Topics Covered:

1 Introduction
1.1 Report description
1.2 Market segmentation
1.3 Scope of the report
1.4 Research methodology
1.5 Assumptions

2 Executive Summary

3 Global Peptide Therapeutics Market Dynamics
3.1 Overview
3.2 Drivers
3.3 Restraints & challenges
3.4 Opportunities
3.5 Porters five forces analysis
3.6 Market attractiveness analysis
3.7 Peptide therapeutics - emerging technologies & trends
3.8 Regulatory policies

4 Global Peptide Therapeutics Market Analysis, By Applications

5 Global Peptide Therapeutics Market, by Route of Administration
5.1 Introduction
5.2 Parenteral Route
5.3 Oral Route
5.4 Pulmonary Route
5.5 Mucosal Route
5.6 Others (Intradermal & Nasal)

6 Peptide Therapeutics Market - Generic & Innovative Segments
6.1 Introduction
6.2 Peptide Therapeutics - Innovative market
6.3 Peptide Therapeutics - Generic market

7 API Peptide Therapeutics Market, In-house Vs CMO
7.1 Introduction
7.2 API peptide therapeutics - In-house market
7.3 Contract Manufacturing Organizations (CMO)

8 Peptide Therapeutics Market, By Technology
8.1 Introduction
8.2 Solid Phase Peptide Synthesis (SPPS)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.4 Hybrid Technology

9 Peptide Therapeutics Market, By
'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
2. Poster & Abstract Entitled 1H-MRS & FDG-PET Studies in the SOD1 G93A - the Use of Stabilized Peptides as a Rationale for Future Treatment in ALS Presented During Annual Northeast ALS Consortium Meeting
3. US Peptides Discusses the Benefit of Human Growth Hormone
4. CEM Wins Peptide Patent Dispute with Biotage
5. Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
7. US Peptides Discusses the Benefit of Human Growth Hormone and IGF-1
8. Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
9. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
10. Tarix Pharmaceuticals Peptide Technology Stimulates Revascularization Following Ischemia
11. US Peptides Discusses IGF 1 in new article series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  IRIDEX Corporation (NASDAQ: IRIX ... quarter 2014 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, July 31, 2014 ... business developments. Interested parties may access the ...
(Date:7/24/2014)... and MENLO PARK, Calif. , July 24, ... ("DelMar" "the company") announced today that the company,s board of ... December 31 to June 30. Accordingly, DelMar will file a ... Jeffrey Bacha , president and CEO of DelMar ... step in achieving our goal of obtaining a senior exchange ...
(Date:7/24/2014)...  Kinex Pharmaceuticals announced the receipt of an allowance ... for the commencement of a Phase I clinical study ... to be allowed by the US FDA in the ... orally active and highly selective inhibitor of Src tyrosine ... of p53, G2/M arrest of proliferating cell populations and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... invivodata inc., the ... and services for global clinical research, today announced ... provide the EXAcerbations of Chronic pulmonary disease Tool ... is a Patient-Reported Outcome (PRO) measure for evaluating ...
... testing in humans watershed moment for unique malaria ... a move that highlights the strength of public-private ... company Sanaria Inc., with support from the PATH ... 1 clinical trial -- the first tests in ...
Cached Medicine Technology:invivodata Certified to Deliver EXACT in COPD Trials 2invivodata Certified to Deliver EXACT in COPD Trials 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 2Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4
(Date:7/24/2014)... (PRWEB) July 25, 2014 Voted one ... of the global clients, BellasDress focuses on providing its ... useful fashion information. Recently, the company has announced its ... in the new range is created according to the ... big discounts, up to 68% off. , As a ...
(Date:7/24/2014)... Triangle Park, NC (PRWEB) July 24, 2014 ... elderly, ethnic minorities, and low-income households are disproportionately ... and public food safety net in the United ... International. , Under Section 743 of the Consolidated ... U.S. Department of Agriculture's Food and Nutrition Service ...
(Date:7/24/2014)... Four Seasons Resort Maui at ... $3 million renovation of the famed Maile suite and ... just in time to welcome summer guests vacationing to ... from the internationally-acclaimed BraytonHughes Design Studios, San Francisco and ... and the largest in Hawaii—received a complete re-envisioning. No ...
(Date:7/24/2014)... Just as fitness and health professionals take ... financial and marketing strength to be important as well. ... next level by using the most powerful communication tools ... Call Tracking and SMS texting solutions . , ... are quickly become integral in marketing and communication methods ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, ... may be dead wrong, according to a small study that asked ... with 33 boys between the ages of 14 and 16, researchers ... for the closeness and trust. Very few boasted about sexual conquests ... with a girl. "In our culture, we have lots of ...
Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3
... Buffalo announced today a $10 million gift from Jeremy M. ... Institute, which will support research and clinical collaboration on the ... ... D. Jacobs, M.D., a world-renowned medical pioneer and the late ...
... 13 Elekta, a world-class leader in,advanced ... virtual patient clinic, enabling clinicians, patients and,the ... themselves with,Elekta,s products* and solutions and how ... clinic, available via http://www.elekta.com/evc , ...
... HILL, N.C., June 13 Long and costly ... to,maximize limited staff and resources to the development ... companies are integrating,commercial insights earlier and earlier into ... and target promising compounds, reduce development cycle,time, focus ...
... in diet and other factors , , FRIDAY, June 13 (HealthDay ... advice to people at high risk of heart disease effectively ... cholesterol and smoking. , "The results we see are very ... Dr. David Wood, a cardiology professor at Imperial College in ...
... Friday 13 June 2008: Rheumatoid arthritis (RA), ... should undergo compulsory cardiovascular (CV) risk management and ... the increased CV risk in inflammatory rheumatic disease ... Management in RA, recommended today at EULAR 2008, ...
... WASHINGTON, June 13 A new "hospital report,card" ... the Department,s,health care system high marks, with VA ... accepted by the health,care industry., "This report ... care VA,provides to our veterans," said Dr. James ...
Cached Medicine News:Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 2Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 3Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 4Health News:Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer 2Health News:Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 2Health News:Lifestyle Counseling Reduces Heart Risk 2Health News:Lifestyle Counseling Reduces Heart Risk 3Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 2Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 3Health News:Health Care 'Report Card' Gives VA High Marks 2
... are individually adjusted for perfect focus where ... on paper. This, along with Keeler's wide ... that whatever the patient's pupil size, you ... of view. Lithium-ion technology provides a longer ...
... 200 ophthalmoscope, the world's ... ophthalmoscope. Heine's aspherical optical ... along with innovative design ... the Beta 200 the ...
... The Heine Beta 200S is ... with a combination of patented ... and a range of corrective ... dpt. in single diopter steps. ...
... The ophthalmoscope with superior aspherical optics. The ... means of the aspherical optical system avoids ... 200 allows you to view the whole ... even with a small pupil. Conventional ophthalmoscopes ...
Medicine Products: